Literature DB >> 29874925

The effect of a commercial competitive exclusion product on the selection of enrofloxacin resistance in commensal E. coli in broilers.

Ilias Chantziaras1, Annemieke Smet2, Maria Eleni Filippitzi1, Bert Damiaans1, Freddy Haesebrouck3, Filip Boyen3, Jeroen Dewulf1.   

Abstract

The effect of a competitive exclusion product (Aviguard®) on the selection of fluoroquinolone resistance in poultry was assessed in vivo in the absence or presence of fluoroquinolone treatment. Two experiments using a controlled seeder-sentinel animal model (2 seeders: 4 sentinels per group) with one-day-old chicks were used. For both experiments, as soon as the chicks were hatched, the birds of two groups were administered Aviguard® and two groups were left untreated. Three days later, all groups were inoculated with an enrofloxacin-susceptible commensal E. coli strain. Five days after hatching, two birds per group were inoculated with either a bacteriologically fit or a bacteriologically non-fit enrofloxacin-resistant commensal E. coli strain. In experiment 2, all groups were orally treated for three consecutive days (days 8-10) with enrofloxacin. Throughout the experiments, faecal excretion of all inoculated E. coli strains was determined on days 2, 5, 8, 11, 18 and 23 by selective plating (via spiral plater). Linear mixed models were used to assess the effect of Aviguard® on the selection of fluoroquinolone resistance. The use of Aviguard® (P < 0.01) reduced the excretion of enrofloxacin-resistant E. coli when no enrofloxacin treatment was administered. However, this beneficial effect disappeared (P = 0.37) when the birds were treated with enrofloxacin. Similarly, bacterial fitness of the enrofloxacin-resistant E. coli strain used for inoculation had an effect (P < 0.01) on the selection of enrofloxacin resistance when no treatment was administered, whereas this effect was no longer present when enrofloxacin was administered (P = 0.70). Thus, enrofloxacin treatment cancelled the beneficial effects from administrating Aviguard® in one-day-old broiler chicks and resulted in an enrofloxacin-resistant flora. RESEARCH HIGHLIGHTS The effect of Aviguard® on the selection of enrofloxacin resistance was assessed in vivo. Without enrofloxacin, Aviguard® reduced the selection of enrofloxacin resistance. When enrofloxacin was administered, it cancelled the beneficial effect of Aviguard®.

Entities:  

Keywords:  Enrofloxacin; antibiotic resistance; antibiotic use; competitive exclusion product; fluoroquinolone resistance selection

Mesh:

Substances:

Year:  2018        PMID: 29874925     DOI: 10.1080/03079457.2018.1486027

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  4 in total

1.  Litter Commensal Bacteria Can Limit the Horizontal Gene Transfer of Antimicrobial Resistance to Salmonella in Chickens.

Authors:  Adelumola Oladeinde; Zaid Abdo; Benjamin Zwirzitz; Reed Woyda; Steven M Lakin; Maximilian O Press; Nelson A Cox; Jesse C Thomas; Torey Looft; Michael J Rothrock; Gregory Zock; Jodie Plumblee Lawrence; Denice Cudnik; Casey Ritz; Samuel E Aggrey; Ivan Liachko; Jonas R Grove; Crystal Wiersma
Journal:  Appl Environ Microbiol       Date:  2022-04-13       Impact factor: 5.005

2.  Antimicrobial resistance clusters in commensal Escherichia coli from livestock.

Authors:  Ayla Hesp; Cajo Ter Braak; Jeanet van der Goot; Kees Veldman; Gerdien van Schaik; Dik Mevius
Journal:  Zoonoses Public Health       Date:  2021-01-17       Impact factor: 2.702

3.  Performance of distinct microbial based solutions in a Campylobacter infection challenge model in poultry.

Authors:  Maxine Ty; Khaled Taha-Abdelaziz; Vanessa Demey; Mathieu Castex; Shayan Sharif; John Parkinson
Journal:  Anim Microbiome       Date:  2022-01-03

4.  A Complex Competitive Exclusion Culture Reduces Campylobacter jejuni Colonization in Broiler Chickens at Slaughter Age In Vivo.

Authors:  Vanessa Szott; Benjamin Reichelt; Anika Friese; Uwe Roesler
Journal:  Vet Sci       Date:  2022-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.